Literature DB >> 10225869

Survival of Enterococcus faecalis in mouse peritoneal macrophages.

C R Gentry-Weeks1, R Karkhoff-Schweizer, A Pikis, M Estay, J M Keith.   

Abstract

Enterococcus faecalis was tested for the ability to persist in mouse peritoneal macrophages in two separate studies. In the first study, the intracellular survival of serum-passaged E. faecalis 418 and two isogenic mutants [cytolytic strain FA2-2(pAM714) and non-cytolytic strain FA2-2(pAM771)] was compared with that of Escherichia coli DH5alpha by infecting BALB/c mice intraperitoneally and then monitoring the survival of the bacteria within lavaged peritoneal macrophages over a 72-h period. All E. faecalis isolates were serum passaged to enhance the production of cytolysin. E. faecalis 418, FA2-2(pAM714), and FA2-2(pAM771) survived at a significantly higher level (P = 0.0001) than did E. coli DH5alpha at 24, 48, and 72 h. Internalized E. faecalis 418, FA2-2(pAM714), and FA2-2(pAM771) decreased 10-, 55-, and 31-fold, respectively, over the 72-h infection period, while internalized E. coli DH5alpha decreased 20, 542-fold. The difference in the rate of survival of E. faecalis strains and E. coli DH5alpha was most prominent between 6 and 48 h postinfection (P = 0.0001); however, no significant difference in killing was observed between 48 and 72 h postinfection. In the second study, additional E. faecalis strains from clinical sources, including DS16C2, MGH-2, OG1X, and the cytolytic strain FA2-2(pAM714), were compared with the nonpathogenic gram-positive bacterium, Lactococcus lactis K1, for the ability to survive in mouse peritoneal macrophages. In these experiments, the E. faecalis strains and L. lactis K1 were grown in brain heart infusion (BHI) broth to ensure that there were equal quantities of injected bacteria. E. faecalis FA2-2(pAM714), DS16C2, MGH-2, and OG1X survived significantly better (P < 0.0001) than did L. lactis K1 at each time point. L. lactis K1 was rapidly destroyed by the macrophages, and by 24 h postinfection, viable L. lactis could not be recovered. E. faecalis FA2-2(pAM714), DS16C2, MGH-2, and OG1X declined at an equivalent rate over the 72-h infection period, and there was no significant difference in survival or rate of decline among the strains. E. faecalis FA2-2(pAM714), MGH-2, DS16C2, and OG1X exhibited an overall decrease of 25-, 55-, 186-, and 129-fold respectively, between 6 and 72 h postinfection. The overall reduction by 1.3 to 2.27 log units is slightly higher than that seen for serum-passaged E. faecalis strains and may be attributable to the higher level of uptake of serum-passaged E. faecalis than of E. faecalis grown in BHI broth. Electron microscopy of infected macrophages revealed that E. faecalis 418 was present within an intact phagocytic vacuole at 6 h postinfection but that by 24 h the infected macrophages were disorganized, the vacuolar membrane was degraded, and the bacterial cells had entered the cytoplasm. Macrophage destruction occurred by 48 h, and the bacteria were released. In conclusion, the results of these experiments indicate that E. faecalis can persist for an extended period in mouse peritoneal macrophages.

Entities:  

Mesh:

Year:  1999        PMID: 10225869      PMCID: PMC115952     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

2.  Interactions of pyridine nucleotides with redox forms of the flavin-containing NADH peroxidase from Streptococcus faecalis.

Authors:  L B Poole; A Claiborne
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

3.  Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells.

Authors:  B Kreft; R Marre; U Schramm; R Wirth
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Uptake of antibiotics by human alveolar macrophages.

Authors:  W L Hand; R W Corwin; T H Steinberg; G D Grossman
Journal:  Am Rev Respir Dis       Date:  1984-06

5.  Plasmid-associated virulence of Salmonella typhimurium.

Authors:  P A Gulig; R Curtiss
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 6.  Enterococcal endocarditis.

Authors:  D W Megran
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

7.  Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.

Authors:  S M Jones; A J Winter
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 8.  Nosocomial bacteremia due to Enterococcus faecalis without endocarditis.

Authors:  W Graninger; R Ragette
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

9.  Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice.

Authors:  Y Ike; H Hashimoto; D B Clewell
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Hemolysin supports survival but not entry of the intracellular bacterium Listeria monocytogenes.

Authors:  M Kuhn; S Kathariou; W Goebel
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  42 in total

1.  Cardiac Microlesions Form During Severe Bacteremic Enterococcus faecalis Infection.

Authors:  Armand O Brown; Kavindra V Singh; Melissa R Cruz; Karan Gautam Kaval; Liezl E Francisco; Barbara E Murray; Danielle A Garsin
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

2.  Pathogenic Mechanisms of Enterococcal Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

3.  Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect.

Authors:  Xingmin Wang; Toby D Allen; Randal J May; Stanley Lightfoot; Courtney W Houchen; Mark M Huycke
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

4.  The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Authors:  Margot Schlusselhuber; Riccardo Torelli; Cecilia Martini; Matthias Leippe; Vincent Cattoir; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Maurizio Sanguinetti; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

5.  Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression.

Authors:  Toby D Allen; Danny R Moore; Xingmin Wang; Viviana Casu; Randal May; Megan R Lerner; Courtney Houchen; Daniel J Brackett; Mark M Huycke
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

6.  Enterococcus faecalis infection activates phosphatidylinositol 3-kinase signaling to block apoptotic cell death in macrophages.

Authors:  Jun Zou; Nathan Shankar
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 7.  Adaptation to Adversity: the Intermingling of Stress Tolerance and Pathogenesis in Enterococci.

Authors:  Anthony O Gaca; José A Lemos
Journal:  Microbiol Mol Biol Rev       Date:  2019-07-17       Impact factor: 11.056

8.  Occurrence, genetic diversity, and persistence of enterococci in a Lake Superior watershed.

Authors:  Qinghong Ran; Brian D Badgley; Nicholas Dillon; Gary M Dunny; Michael J Sadowsky
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

9.  Sex pheromone response, clumping, and slime production in enterococcal strains isolated from occluded biliary stents.

Authors:  Gianfranco Donelli; Claudia Paoletti; Lucilla Baldassarri; Emilio Guaglianone; Roberta Di Rosa; Gloria Magi; Cinzia Spinaci; Bruna Facinelli
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  An AraC-type transcriptional regulator encoded on the Enterococcus faecalis pathogenicity island contributes to pathogenesis and intracellular macrophage survival.

Authors:  Phillip S Coburn; Arto S Baghdayan; G T Dolan; Nathan Shankar
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.